Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 16, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc.
| -23.63K |
$5.67 | -$133,970.76 | -4.08% | 556.05K |
Mar 14
| |||||||
Allogene Therapeutics, Inc.
| -3.00K |
$6.85 | -$20,550.00 | -0.52% | 577.68K |
Feb 13
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| -3.00K |
$7.04 | -$21,120.00 | -0.51% | 580.68K |
Jan 17
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| -5.60K |
$7.53 | -$42,186.42 | -0.95% | 583.68K |
Dec 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 175.44K |
—
|
—
| +42.39% | 589.28K |
Mar 23
| |||||||
Allogene Therapeutics, Inc.
| -8.85K |
$7.68 | -$67,962.09 | -2.09% | 413.84K |
Mar 15
| |||||||
Allogene Therapeutics, Inc.
|
0
|
$13.52 | -$112,494.50 |
—
| 421.67K |
Sep 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$11.64 | -$93,644.00 |
—
| 421.35K |
Aug 16
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$11.91 | -$96,403.00 |
—
| 421.35K |
Jul 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$13.80 | -$115,250.00 |
—
| 421.35K |
Jun 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$16.14 | -$138,650.00 |
—
| 421.35K |
May 18
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$15.29 | -$130,125.50 |
—
| 421.35K |
May 17
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$17.16 | -$297,817.36 |
—
| 421.35K |
Apr 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 22.2K |
—
|
—
| +5.56% | 421.35K |
Mar 26
| |||||||
Allogene Therapeutics, Inc.
| -6.62K |
$20.11 | -$608,098.37 | -1.63% | 399.15K |
Mar 15
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 51.5K |
$2.27 | $116,905.00 | +14.55% | 405.4K |
Dec 17
| |||||||
Allogene Therapeutics, Inc.
|
0
|
$21.14 | -$377,300.00 |
—
| 353.9K |
Oct 6
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$19.40 | -$856,162.73 |
—
| 353.9K |
Oct 1
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$18.82 | -$827,216.00 |
—
| 353.9K |
Sep 1
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| -6.55K |
$19.58 | -$1,107,370.81 | -1.82% | 353.9K |
Aug 3
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.